STUDY OF PATIENTS WITH STAGE III BREAST CANCER WHO RECEIVED NEOADJUVANT CHEMOTHERAPY

被引：0
|
作者：
Iwakuma, N. [1 ]
Toh, U. [1 ]
Takahashi, R. [1 ]
Mishima, M. [1 ]
Takenaka, M. [1 ]
Koura, K. [1 ]
Fujii, T. [1 ]
Shirouzu, K. [1 ]
机构：
[1] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan
来源：
BREAST | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S102 / S102
页数：1
相关论文
共 50 条
  • [31] Breast-Conserving Surgery after Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients
    Shin, H-C
    Han, W.
    Moon, H-C
    Im, S-A
    Park, S-J
    Noh, D-Y
    CANCER RESEARCH, 2012, 72
  • [32] Prognostic Significance of Internal Mammary Node Involvement in Patients With Clinical Stage IIIC Breast Cancer Who Received Neoadjuvant Chemotherapy, Surgery, and Radiation Therapy
    Noh, J.
    Kim, K.
    Park, W.
    Suh, C.
    Huh, S.
    Choi, D.
    Kim, Y.
    Keum, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S259 - S259
  • [33] Radiation is an important component of therapy for patients with stage III breast cancer who achieve a pathological complete response after neoadjuvant chemotherapy
    McGuire, SE
    Gonzalez-Angulo, AM
    Tucker, SL
    Rouzier, R
    Strom, EA
    Perkins, GH
    Oh, JL
    Huang, EH
    Sahin, AA
    Hunt, KK
    Hortobagyi, GN
    Buchholz, TA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S52 - S52
  • [34] Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy
    Wang, Xiaoxia
    Tan, Yuchuan
    Liu, Daihong
    Shen, Hesong
    Deng, Yongchun
    Tan, Yong
    Wang, Lei
    Zhang, Yipeng
    Ma, Xin
    Zeng, Xiaohua
    Zhang, Jiuquan
    EUROPEAN RADIOLOGY, 2022, 32 (07) : 4898 - 4908
  • [35] Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy
    Xiaoxia Wang
    Yuchuan Tan
    Daihong Liu
    Hesong Shen
    Yongchun Deng
    Yong Tan
    Lei Wang
    Yipeng Zhang
    Xin Ma
    Xiaohua Zeng
    Jiuquan Zhang
    European Radiology, 2022, 32 : 4898 - 4908
  • [36] Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy
    Martei, Yehoda M.
    Narasimhamurthy, Mohan
    Setlhako, Dipho, I
    Ayane, Gezahen
    Ralefala, Tlotlo
    Chiyapo, Sebathu
    Gross, Robert
    Shulman, Lawrence N.
    Grover, Surbhi
    DeMichele, Angela
    JCO GLOBAL ONCOLOGY, 2022, 8
  • [37] Absence of estrogen receptor is associated with worse oncologic outcome in patients who were received neoadjuvant chemotherapy for breast cancer
    Park, Young Ryul
    Lee, Jeeyeon
    Jung, Jin Hyang
    Kim, Wan Wook
    Park, Chan Sub
    Lee, Ryu Kyung
    Chae, Yee Soo
    Lee, Soo Jung
    Park, Ji-Young
    Park, Jee Young
    Park, Ho Yong
    ASIAN JOURNAL OF SURGERY, 2020, 43 (03) : 467 - 475
  • [38] Plasma miR-221 as a Predictive Biomarker for Chemoresistance in Breast Cancer Patients who Previously Received Neoadjuvant Chemotherapy
    Zhao, Ruihua
    Wu, Jiannan
    Jia, Weijuan
    Gong, Chang
    Yu, Fengyan
    Ren, Zefang
    Chen, Kai
    He, Jianrong
    Su, Fengxi
    ONKOLOGIE, 2011, 34 (12): : 675 - 680
  • [39] Neoadjuvant chemotherapy of stage III breast cancer with paclitaxel: Investigations of chemoresistance in vivo
    Lonning, PE
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 28 - 28
  • [40] A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy
    Matsuda, Naoko
    Hayashi, Naoki
    Ohde, Sachiko
    Yagata, Hiroshi
    Kajiura, Yuka
    Yoshida, Atsushi
    Suzuki, Koyu
    Nakamura, Seigo
    Tsunoda, Hiroko
    Yamauchi, Hideko
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (08) : 764 - 769
12345